User:Mr. Ibrahem/Latanoprostene bunod

Latanoprostene bunod, sold under the brand name Vyzulta, is a medication used to treat increased intraocular pressure in open-angle glaucoma and ocular hypertension. It is used as an eye drop.

Common side effects include eye pain and eye redness. Other side effects may include bacterial keratitis, macular edema, darkening of the skin around the eye, and eyelash changes. It is a prostaglandin which increases outflow through the trabecular meshwork and uveoscleral pathway.

Latanoprostene bunod was approved for medical use in the United States in 2017. In the United States it costs about 230 USD for a 2.5 ml bottle as of 2021. As of 2021 it is not commercially available in the United Kingdom or Europe.